• Mutation; HGNC; 11998; TP53; Simple; p.Val272Glu (c.815T>A); ClinVar=VCV000376673; Zygosity=Unspecified (PubMed=10732753; DepMap).
  

PubMed=8026890; DOI=10.1002/ijc.2910580223
Thomson J.A.F., Leonard J.H., McGregor K., Sturm R.A., Parsons P.G.
A nonconsensus octamer-recognition sequence (TAATGARAT-motif) identifies a novel DNA binding protein in human Merkel cell carcinoma cell lines.
Int. J. Cancer 58:285-290(1994)

PubMed=7814141; DOI=10.1002/ijc.2910600115
Leonard J.H., Dash P., Holland P., Kearsley J.H., Bell J.R.
Characterisation of four Merkel cell carcinoma adherent cell lines.
Int. J. Cancer 60:100-107(1995)

PubMed=10732753; DOI=10.1054/bjoc.1999.1006
Van Gele M., Kaghad M., Leonard J.H., Van Roy N., Naeyaert J.M., Geerts M.L., Van Belle S., Cocquyt V., Bridge J., Sciot R., De Wolf-Peeters C., De Paepe A., Caput D., Speleman F.
Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
Br. J. Cancer 82:823-826(2000)

PubMed=11433400; DOI=10.1002/ijc.1352
Cook A.L., Pollock P.M., Welch J., Walsh M.D., Bowman R.V., Baumann K.C., Hayward N.K., Leonard J.H.
CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin.
Int. J. Cancer 93:361-367(2001)

PubMed=12209986; DOI=10.1002/ijc.10554
Leonard J.H., Cook A.L., Van Gele M., Boyle G.M., Inglis K.J., Speleman F., Sturm R.A.
Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma.
Int. J. Cancer 101:103-110(2002)